Atlas Trials

Phase II Open Label Study Using Triheptanoin in Patients With Glucose Type 1 Transporter Deficiency GLUT1-DS

Clinical trial NCT02014883 · COMPLETED

Trial details

NCT number
NCT02014883
Sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Glut1 Deficiency Syndrome
Start date
2013-12-04
Primary completion
2019-07-04
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.